DAYTON, N.J. — Aurobindo Pharma Ltd. has gained Food and Drug Administration approval for alprazolam tablets, a medication for anxiety.
Aurobindo said its alprazolam product — available in dosages of 0.25 mg, 0.5 mg, 1 mg and 2 mg — is a generic version of Xanax tablets from Pfizer Inc.
Part of a group of drugs known as benzodiazepines, alprazolam works by slowing down the movement of chemicals in the brain that may become unbalanced, resulting in a reduction in nervous tension. The medication is used for the treatment of anxiety disorders as well as panic disorders and anxiety caused by depression.
Alprazolam had U.S. sales of approximately $102.7 million for the 12 months ended in June 2015, according to IMS Health data reported by Aurobindo.
